Critical Care Therapeutics Market by Drug Class and Geography - Forecast and Analysis 2021-2025

Executive Summary

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

• Fiver forces analysis
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by drug class

• Market segments
• Comparison by Drug class
• Albumin - Market size and forecast 2020-2025
• Antithrombin concentrates - Market size and forecast 2020-2025
• Prothrombin complex concentrates - Market size and forecast 2020-2025
• Factor XIII concentrates - Market size and forecast 2020-2025
• Fibrinogen concentrates - Market size and forecast 2020-2025
• Market opportunity by Drug class

Customer landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2020-2025
• Europe - Market size and forecast 2020-2025
• Asia - Market size and forecast 2020-2025
• ROW - Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Vendor landscape
• Landscape disruption
• Industry risks
• Competitive scenario

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Baxter International Inc.
• Bristol-Myers Squibb Co.
• CSL Ltd.
• Grifols SA
• Kedrion Spa
• LFB SA
• Novartis AG
• Octapharma AG
• Pfizer Inc.
• Takeda Pharmaceutical Co. Ltd.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations